Rockefeller Capital Management
RVMD icon

Rockefeller Capital Management’s Revolution Medicines RVMD Stock Holding History

Rockefeller Capital Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$8.15M Buy
39,705
+25,625
+182% +$5.08M 0.01% 813
2026
Q2 		$2.64M Buy
14,080
+12,399
+738% +$1.81M ﹤0.01% 1254
2026
Q1 		$163K Buy
1,681
+1,083
+181% +$109K ﹤0.01% 2615
2025
Q4 		$47.6K Buy
598
+271
+83% +$17.8K ﹤0.01% 3094
2025
Q3 		$15.3K Buy
+327
New +$12.8K ﹤0.01% 3477

Other funds holding RVMD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Alphabet Inc
Alphabet Inc Mountain View, California $88.3B AUM 46.07% 1-Year Est. Return

Rockefeller Capital Management's RVMD Position: Q3 2026 in Review

Rockefeller Capital Management increased its Revolution Medicines (RVMD) stake by 182% in Q3 2026, buying an estimated $5.08M and bringing the position to 39,705 shares worth $8.15M. The position accounts for 0.01% of the portfolio, ranked #813.

Rockefeller Capital Management first reported a position in RVMD in Q3 2025 and has held it in 5 quarters since. 577 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

  • Rockefeller Capital Management held 39,705 shares of Revolution Medicines worth $8.15M as of Q3 2026.
  • Rockefeller Capital Management bought 25,625 Revolution Medicines shares in Q3 2026, an estimated $5.08M.
  • Revolution Medicines made up 0.01% of Rockefeller Capital Management's portfolio in Q3 2026, its #813 holding.
  • Rockefeller Capital Management first reported a position in Revolution Medicines in Q3 2025 and has held it in 5 quarters since.
  • 577 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on Rockefeller Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.